Sirius Neosight
French tech company | Builders Republic
About
Oncology diagnostics company developing a blood test that detects and isolates circulating tumour cells by measuring cell-membrane fluidity — giving clinicians a less invasive way to spot cancer early, monitor relapse and assess whether a treatment is working, spun out of CNRS and the Léon Bérard cancer centre.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2023
- City
- TASSIN-LA-DEMI-LUNE
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 4.0 M€ raised since 2020
Funding rounds
- Seed — 2025